Lundbeck handed massive fine
The European Commission has ruled that agreements between Danish company Lundbeck and four generics manufacturers violated European competition law and has therefore handed the company a massive fine – the largest ever of its kind involving a Danish company. Lundbeck calls it disappointing and intends to appeal the decision.
by Stefan Singh Kailay
It was a violation of European competition law when Lundbeck made deals with four generics manufacturers concerning its antidepressant citalopram, the European Commission has decided according to a press release from the Danish company, which also reveals Lundbeck’s intentions to appeal the decision.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
